AstraZeneca vaccine sales jump to $894 mln, submission for U.S. approval delayed ...Middle East

AstraZeneca's COVID-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months, and the drugmaker updated its 2021 forecasts on Thursday to include sales from its Alexion unit.

Hence then, the article about astrazeneca vaccine sales jump to 894 mln submission for u s approval delayed was published today ( Thursday 29/07/2021 - 10:30 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca vaccine sales jump to $894 mln, submission for U.S. approval delayed )

Also on site :

• Trump’s right about boosting US military spending — but he should threaten our enemies, not our allies
• The gamification of graphic porn is catastrophic to our society — as it alters the minds and souls of children
• UPDATE 1-Homeland Security says Portland driver 'weaponized' vehicle before shooting